Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Increases By 1,044.5%

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totaling 147,787 shares, a growth of 1,044.5% from the March 15th total of 12,913 shares. Approximately 0.3% of the shares of the company are sold short. Based on an average daily volume of 969,940 shares, the short-interest ratio is currently 0.2 days.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC bought a new position in shares of Zhengye Biotechnology in the second quarter worth about $1,158,000. WINTON GROUP Ltd raised its stake in shares of Zhengye Biotechnology by 193.8% in the fourth quarter. WINTON GROUP Ltd now owns 63,297 shares of the company’s stock worth $73,000 after buying an additional 41,750 shares during the period. XTX Topco Ltd raised its stake in shares of Zhengye Biotechnology by 71.4% in the fourth quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock worth $68,000 after buying an additional 24,697 shares during the period. Invesco Ltd. bought a new position in shares of Zhengye Biotechnology in the second quarter worth about $220,000. Finally, Geode Capital Management LLC bought a new position in shares of Zhengye Biotechnology in the second quarter worth about $174,000.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Zhengye Biotechnology in a research report on Friday, January 9th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Zhengye Biotechnology has an average rating of “Sell”.

Zhengye Biotechnology Stock Up 7.1%

NASDAQ ZYBT opened at $1.06 on Friday. The stock’s 50-day moving average price is $0.88 and its 200-day moving average price is $1.63. Zhengye Biotechnology has a 52 week low of $0.68 and a 52 week high of $14.30.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.